Trial Profile
Phase IIb Chemoprevention Trial of Difluoromethylornithine (DFMO) in Human Subjects With Intestinal-type Barrett's Esophagus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Eflornithine (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 24 Sep 2005 New trial record.